MA39566A1 - Composition diététique présentant une activité antidyslipidémique - Google Patents

Composition diététique présentant une activité antidyslipidémique

Info

Publication number
MA39566A1
MA39566A1 MA39566A MA39566A MA39566A1 MA 39566 A1 MA39566 A1 MA 39566A1 MA 39566 A MA39566 A MA 39566A MA 39566 A MA39566 A MA 39566A MA 39566 A1 MA39566 A1 MA 39566A1
Authority
MA
Morocco
Prior art keywords
dietary composition
dyslipidemic
activity
relates
present
Prior art date
Application number
MA39566A
Other languages
English (en)
Inventor
Francesco Melani
Alida Agostini
Original Assignee
Berlin Chemie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie Ag filed Critical Berlin Chemie Ag
Publication of MA39566A1 publication Critical patent/MA39566A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Dans un aspect général, la présente invention concerne une composition diététique présentant une activité antidyslipidémique améliorée. Plus spécifiquement, la présente invention concerne une composition diététique comprenant une combinaison d'un micro-organisme choisi parmi les levures de riz rouges, d'un alcool linéaire aliphatique, de niacine ou ses dérivés et de stérols et/ou de stanols d'origine végétale sous forme libre ou estérifiée.
MA39566A 2014-07-18 2015-07-17 Composition diététique présentant une activité antidyslipidémique MA39566A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM20140401 2014-07-18
PCT/IB2015/055430 WO2016009403A1 (fr) 2014-07-18 2015-07-17 Composition diététique présentant une activité antidyslipidémique

Publications (1)

Publication Number Publication Date
MA39566A1 true MA39566A1 (fr) 2018-08-31

Family

ID=51655865

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39566A MA39566A1 (fr) 2014-07-18 2015-07-17 Composition diététique présentant une activité antidyslipidémique

Country Status (22)

Country Link
EP (1) EP3169322B1 (fr)
KR (1) KR102440770B1 (fr)
CN (1) CN106659679A (fr)
AU (1) AU2015291203B2 (fr)
CO (1) CO2017001560A2 (fr)
CY (1) CY1124324T1 (fr)
DK (1) DK3169322T3 (fr)
ES (1) ES2833323T3 (fr)
HR (1) HRP20201824T1 (fr)
HU (1) HUE052786T2 (fr)
LT (1) LT3169322T (fr)
MA (1) MA39566A1 (fr)
MX (1) MX380116B (fr)
MY (1) MY186102A (fr)
PE (1) PE20170902A1 (fr)
PL (1) PL3169322T3 (fr)
PT (1) PT3169322T (fr)
RS (1) RS61160B1 (fr)
SG (1) SG11201700417XA (fr)
SI (1) SI3169322T1 (fr)
SM (1) SMT202000658T1 (fr)
WO (1) WO2016009403A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111629784A (zh) * 2018-01-04 2020-09-04 纯护理专业有限责任公司 用于调节总血液胆固醇的天然组合产品和方法
WO2020208404A1 (fr) * 2019-04-11 2020-10-15 Pharmanutrition R&D S.r.l. Composition de poudre hautement disponible contenant du riz rouge
GB202200008D0 (en) * 2022-01-01 2022-02-16 Meda Pharma S P A Compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2488617A1 (fr) * 2002-06-10 2003-12-18 Eugene R. Cooper Preparation de sterols nanoparticulaires et nouvelles combinaisons de sterols
CN1672712A (zh) * 2004-03-25 2005-09-28 李安国 降低血脂的新组方及其制剂制备方法
US20080103118A1 (en) 2006-10-27 2008-05-01 Iomedix Development International Srl Composition for improving blood cholesterol levels
US8815310B2 (en) * 2011-01-10 2014-08-26 Morteza Naghavi Compositions for boosting metabolism, assisting weight loss, and promoting cardiovascular health
US20120270849A1 (en) 2011-04-20 2012-10-25 Prosoft Software, Inc. Combinations of niacin, omega-3 and plant sterols/stanols for prevention cholesterol treatment
EP2744355B1 (fr) 2011-08-15 2016-09-21 Unilever N.V. Composition comestible comprenant du stérol

Also Published As

Publication number Publication date
AU2015291203A1 (en) 2017-03-09
SI3169322T1 (sl) 2021-01-29
PE20170902A1 (es) 2017-07-12
CY1124324T1 (el) 2022-03-24
PL3169322T3 (pl) 2021-04-19
SMT202000658T1 (it) 2021-01-05
CO2017001560A2 (es) 2017-05-19
DK3169322T3 (da) 2020-11-16
NZ729232A (en) 2022-03-25
HRP20201824T1 (hr) 2021-01-08
KR102440770B1 (ko) 2022-09-06
EP3169322A1 (fr) 2017-05-24
PT3169322T (pt) 2020-12-04
WO2016009403A1 (fr) 2016-01-21
RS61160B1 (sr) 2021-01-29
KR20170030641A (ko) 2017-03-17
EP3169322B1 (fr) 2020-09-09
CN106659679A (zh) 2017-05-10
LT3169322T (lt) 2020-12-10
ES2833323T3 (es) 2021-06-14
MX380116B (es) 2025-03-11
HUE052786T2 (hu) 2021-05-28
MX2017000740A (es) 2017-10-12
MY186102A (en) 2021-06-22
AU2015291203B2 (en) 2020-03-12
SG11201700417XA (en) 2017-02-27

Similar Documents

Publication Publication Date Title
MA40671B1 (fr) Anticorps anti-c10orf54 et leurs utilisations
PH12018500843B1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
MX2014003832A (es) Molecula de union al antigeno que induce la inmunorespuesta al antigeno objetivo.
BR112017024928A2 (pt) Métodos para prevenção da diabetes ou pré- diabetes em um indivíduo, para melhoria da resposta à glicose em um indivíduo com intolerância à glicose, para manutenção da resposta à glicose em um indivíduo com tolerância à glicose e para melhoria da saúde de um indivíduo, composição probiótica e composição farmacêutica
MA46990B1 (fr) Compositions glp-1 et ses utilisations
MA38406A1 (fr) Virus de la maladie de newcastle et leurs utilisations
WO2016060996A3 (fr) Compositions d'interleukine-15 et leurs utilisations
NZ743964A (en) Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab
MX359949B (es) Anticuerpos para troponina i y metodos de uso de los mismos.
BR112014026755B8 (pt) anticorpos contra claudin 18.2 úteis no diagnóstico de câncer
BR112014004444A2 (pt) composições e métodos que compreendem uma variante de enzima lipolítica
UA104005C2 (ru) 2-оксо-1,2-дигидрохинолиновые модуляторы иммунной функции
MX2012003555A (es) Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma.
MA32899B1 (fr) Combinaisons anticancereuses contenant des anticorps reconnaissant specifiquement cd38 et de la cytarabine
MA38567A1 (fr) Variantes de pertuzumab et leur évaluation
MX384802B (es) Composicion que contiene quitina y proteinas digeribles.
EP3988673A3 (fr) Variants de tnfsf15 et dcr3 associés à la maladie de crohn
NZ726521A (en) Pesticidal compositions and processes related thereto
EP3878445A3 (fr) Formulations d'acamprosate, leurs procédés d'utilisation et combinaisons les comprenant
BR112018071602A2 (pt) compostos de imidazopiridina substituídos como inibidores da indolamina 2,3-dioxigenase e/ou triptofano-2,3-dioxigenase
NZ701463A (en) Anti-phytopathogenic composition
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
MX384185B (es) Composicion en forma de emulsion de aceite en agua que comprende semillas molidas en mostaza blanca o amarilla.
MA39566A1 (fr) Composition diététique présentant une activité antidyslipidémique
CO2020015124A2 (es) Anticuerpo anti-tlr7 humano